Researchers are exploring a new treatment strategy for multiple myeloma, a type of blood cancer that often becomes resistant to therapy. They found that a low dose of the...
Scientists are using advanced computer programs to design better therapeutic antibodies. These antibodies are crucial for treating various diseases, but sometimes, the patient’s body sees them as foreign and...
Scientists have been working to improve therapeutic antibodies, which are important tools for treating diseases like cancer and autoimmune disorders. A key challenge is making these antibodies less likely...
Prince Mahidol Award Youth Program Conference 2025 Focuses on Immunotherapy in Solid TumorsBangkok, Thailand The Prince Mahidol Award Youth Program Conference 2025 will take place on January 28, 2025,...
Center of Multidisciplinary Technology for Advanced Medicine (CMUTEAM) Faculty of Medicine, Chiang Mai University For more details, please visit their:Official website: https://w2.med.cmu.ac.th/omics/en/#navigationFacebook page: https://www.facebook.com/CMUTEAM/ Facebook Twitter Line
Cell Engineering for Cancer Therapy Research Group, Faculty of Science, Chiang Mai University For more details, please visit their:Official website: Facebook page: Facebook Twitter Line
CD99 is highly expressed in T cell acute lymphoblastic leukemia (T-ALL), a type of cancer. One promising treatment involves a mouse monoclonal antibody against CD99 called mAb MT99/3, which...
A new humanized antibody, derived from a mouse antibody, has been engineered to target CD99, a protein overexpressed in T-cell acute lymphoblastic leukemia (T-ALL) and T-lymphoblastic lymphoma (T-LBL). The...
Innovations and Networks in Immunotherapy: Bridging Academia and Clinical Applications! Date: December 18, 2024Time: 8:30 AM – 5:00 PMVenue: Chiang Mai University Don’t miss the “Innovations and Networks in...
A follow-up study on 50 adults investigated the impact of PM2.5 exposure on ocular health. Samples were collected before and after the high PM2.5 season, utilizing data from the...